Recent CYTK Stock Price | CYTK Stock Predictions | |
$41.62 | ![]() +96.08% |
$81.61 |
Recent CYTK Analyst Ratings Breakdown, Making CYTK Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 12 | 11 | 11 | 12 |
Buy ratings: | 3 | 3 | 3 | 3 |
Hold ratings: | 4 | 4 | 4 | 4 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.58 | 1.61 | 1.61 | 1.58 |
For the CYTK stock predictions from the analysts covering Cytokinetics Inc, we have collected all of the individual CYTK stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 18 different analysts covering CYTK (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CYTK stock predictions may vary widely, another useful metric to consider is the median CYTK stock prediction, which represents the price at which half of the analysts
made CYTK stock predictions that were higher and half made CYTK stock predictions that were lower. This makes for a different take on the CYTK stock predictions out there, as compared to average or mean.
And that median across all the individual CYTK stock predictions was: $79.0 as of 2025-02-14.
The very highest of the CYTK stock predictions for one year price target was $120.0, while the very lowest of the CYTK stock predictions in the analyst group was
$60.0 (with a standard deviation of $16.835). Get the latest Zacks research report on CYTK — FREE
Find out: CYTK next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
IONS Stock Predictions
POST Stock Predictions
VEL Stock Predictions
ECPG Stock Predictions
SBNY Stock Predictions
SKM Stock Predictions
CVA Stock Predictions
THO Stock Predictions
GOL Stock Predictions
![]()
![]() |
![]() ![]() |
![]() ![]() |
![]() ![]() |
![]() Strong Buy (3.57 out of 4) 63rd percentile
(ranked higher than approx. 63% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com ![]() |
![]() ![]() |